Cite
King CS, Flaherty KR, Glassberg MK, et al. A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen. Ann Am Thorac Soc. 2021;doi: 10.1513/AnnalsATS.202107-864OC.
King, C. S., Flaherty, K. R., Glassberg, M. K., Lancaster, L., Raghu, G., Swigris, J. J., Argula, R. G., Dudenhofer, R. A., Ettinger, N. A., Feldman, J., Johri, S., Fernandes, P., Parsley, E., Shah, P., & Nathan, S. D. (2021). A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen. Annals of the American Thoracic Society, . https://doi.org/10.1513/AnnalsATS.202107-864OC
King, Christopher S, et al. "A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen." Annals of the American Thoracic Society vol. (2021). doi: https://doi.org/10.1513/AnnalsATS.202107-864OC
King CS, Flaherty KR, Glassberg MK, Lancaster L, Raghu G, Swigris JJ, Argula RG, Dudenhofer RA, Ettinger NA, Feldman J, Johri S, Fernandes P, Parsley E, Shah P, Nathan SD. A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen. Ann Am Thorac Soc. 2021 Oct 22; doi: 10.1513/AnnalsATS.202107-864OC. Epub 2021 Oct 22. PMID: 34678128.
Copy
Download .nbib